Macular Toxoplasmosis- Treatment with Intravitreal Clindamycin and Dexamethasone

Hidalgo Torres A, Cubero Parra Jm, Laborda Guirao T, à lvarez Gómez Am, DíazMesa V and Cerdán Palacios D
Additional contact information
Cerdán Palacios D: Hospital Arruzafa, Córdoba, Spain

Biomedical Journal of Scientific & Technical Research, 2023, vol. 49, issue 1, 40237-40239

Abstract: Two cases of macular toxoplamosis treated with intravitreal injections of clindamycin (1mg/0.1ml) and dexamethasone (0.4mg/0.1ml) are reported. First case, 16-year-old feminine adolescent with macular retinitis was treated with intravitreal injection of clindamycin (1mg/0.1ml) and dexamethasone (0.4mg/0.1ml), as well as treatment with trimetropim-sulfamethoxazole and oral prednisone

Keywords: Journals on Medical Drug and Therapeutics; Journals on Emergency Medicine; Physical Medicine and Rehabilitation; Journals on Infectious Diseases Addiction Science and Clinical Pathology; Open Access Clinical and Medical Journal; Journals on Biomedical Science; List of Open Access Medical Journal; Journals on Biomedical Engineering; Open Access Medical Journal; Biomedical Science Articles; Journal of Scientific and Technical Research (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.007734.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.007734.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:49:y:2023:i:1:p:40237-40239

DOI: 10.26717/BJSTR.2023.49.007734

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().